Oncotelic Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!About OTLC
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
CEOVuong Trieu
CEOVuong Trieu
Employees40
Employees40
HeadquartersAgoura Hills, California
HeadquartersAgoura Hills, California
Founded1988
Founded1988
Employees40
Employees40
OTLC Key Statistics
Market cap20.95M
Market cap20.95M
Price-Earnings ratio-5.04
Price-Earnings ratio-5.04
Dividend yield—
Dividend yield—
Average volume101.27K
Average volume101.27K
High today$0.0512
High today$0.0512
Low today$0.0507
Low today$0.0507
Open price$0.0512
Open price$0.0512
Volume35.00K
Volume35.00K
52 Week high$0.07
52 Week high$0.07
52 Week low$0.017
52 Week low$0.017